Exploring the Role of Epigenetics in Cancer Development and Treatment

Thesis Abstract

Abstract
Cancer remains a significant health challenge globally, with increasing emphasis placed on understanding the underlying mechanisms of cancer development and identifying novel treatment strategies. Epigenetics, the study of heritable changes in gene expression that do not involve alterations in the DNA sequence, has emerged as a critical area of research in cancer biology. This thesis aims to explore the role of epigenetics in cancer development and treatment, focusing on how epigenetic modifications contribute to tumorigenesis and the potential of targeting epigenetic pathways for therapeutic interventions. The introduction sets the stage by providing an overview of cancer as a complex disease and the significance of epigenetic mechanisms in regulating gene expression and cell behavior. The background of the study delves into the basics of epigenetics, highlighting key epigenetic modifications such as DNA methylation, histone modifications, and non-coding RNAs, and their relevance to cancer biology. The problem statement underscores the gaps in current knowledge regarding the specific epigenetic alterations implicated in different types of cancer and the challenges in translating epigenetic research into clinical applications. The objectives of the study include elucidating the specific epigenetic changes associated with cancer development, evaluating the potential of epigenetic biomarkers for early detection and prognosis, and exploring the therapeutic strategies targeting epigenetic pathways. The limitations of the study are acknowledged, including the complexity of epigenetic interactions, the heterogeneity of cancer types, and the challenges in developing effective epigenetic therapies. The scope of the study outlines the focus on selected epigenetic modifications and their impact on specific cancer types, providing a framework for the research. The significance of the study lies in its potential to uncover novel biomarkers for cancer diagnosis and prognosis, identify druggable epigenetic targets for precision medicine approaches, and ultimately improve patient outcomes in cancer treatment. The structure of the thesis is outlined to guide the reader through the subsequent chapters, which include a comprehensive literature review on epigenetic alterations in cancer, a detailed research methodology for investigating epigenetic changes, a discussion of the findings from experimental studies, and a conclusion summarizing the key insights and implications of the research. In conclusion, this thesis aims to advance our understanding of the role of epigenetics in cancer development and treatment, highlighting the intricate interplay between epigenetic modifications and oncogenic pathways. By elucidating the epigenetic landscape of cancer, this research seeks to pave the way for personalized therapies that target specific epigenetic vulnerabilities in cancer cells, leading to more effective and tailored treatment strategies in the fight against cancer.